Spots Global Cancer Trial Database for d816v
Every month we try and update this database with for d816v cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation | NCT01266369 | Mastocytosis | masitinib | 18 Years - | AB Science | |
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | NCT04996875 | Advanced System... SM With an Asso... Mast Cell Leuke... Aggressive Syst... | bezuclastinib | 18 Years - | Cogent Biosciences, Inc. | |
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis | NCT05186753 | SSM Mastocytosis, I... Mastocytosis, S... Mastocytosis | Bezuclastinib T... Bezuclastinib T... Placebo Tablets | 18 Years - | Cogent Biosciences, Inc. |